Search for a funded project
Explorez notre base de projets financés
Development of SARS-CoV-2 vaccines – DC-CoVaC
and easier to produce. Moreover, all Human coronaviruses enter their host cells using the trimeric t [...] transmembrane spike (S) glycoprotein. The coronavirus’ S protein represents a major target for the human
Development of Succinate-based analogues and formulations against SARS-CoV-2 and influenza viruses-induced respiratory infections – SuccesS
viruses is a major concern. Those viruses include coronaviruses such as SARS-CoV-2 and influenza A viruses (IAV) [...] There are currently no efficient drugs against coronaviruses and the efficacy of anti-IAV drugs is disputed [...] impairs vaccine protection. Besides, previous coronaviruses crises showed that poorly neutralizing antibodies
Development of embryonic lymphoid cells that shape the thymic architecture – DELSTAR
infections such as influenza or different types of coronavirus. In this project we will investigate the first
Early identification of risk associated with drugs used in COVID-19: analysis of global pharmacovigilance data – Vigi-Drugs COVID-19
Early Identification of Drug Risk in COVID-19: Analysis of Global Pharmacovigilance Data
Ecoepidemiology of coronaviruses, from wildlife to the human population, and assessment of the emerging potential – EPICOREM
environmental changes. Among RNA viruses, coronaviruses (CoVs) are unique in that, on the one hand, [...] will prove attractive to French experts on coronaviruses, and other experts in wildlife, and enable complex
Emerging SARS-CoV-2 variants: intersection of entry routes and antiviral responses – VERSATILE
antiviral strategies against circulating and future coronaviruses.
Endothelial damage and repair in SARS-CoV-2 related vascular injury – ENDOCOV-19
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2
Engineering nanobinders to block SARS-CoV-2 entry – SARS2BlockEntry
The novel coronavirus SARS-CoV-2 has recently emerged as a human pathogen in China’s Hubei province, [...] high-titer neutralizing antibodies in others coronaviruses and to fold independently from other spike domains
Functional Interrogation of SARS-CoV-2 RNA-Host Binding Proteins in viral replication – FISHBP
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 pandemic
Genome-wide CRISPR screens for drug target identification and inhibition of SARS-CoV-2 replication – CRISPR-TARGET-CoV
y syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of the current coronavirus disease 2019 [...] global economic crisis. SARS-CoV-2 is the seventh coronavirus identified as capable of infecting humans and